A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna, Inc. (NASDAQ:MRNA) is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at ...
Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a ...
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
According to the CDC, bird flu has caused recent human cases in dairy and poultry workers in the United States, though the ...
Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said. A California child ...
NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird flu with its revolutionary ...
The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.
A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye ...